Physician profile
Deepak Asti
NPI 1154633600
$12,603.83
in general payments reported to CMS, 2019-2025
36 companies · $1,225 in 2025
The $1,225 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,892 · 2020: $1,442 · 2021: $2,888 · 2022: $2,645 · 2023: $1,108 · 2024: $1,405 · 2025: $1,225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,737.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,737.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,799.56 | 2019-2020 | |
| Abbott Laboratories | $1,559.35 | 2019-2024 | Diamondback Peripheral, Jeti Peripheral Catheter, Supera |
| Abiomed | $1,500.84 | 2020-2025 | Impella |
| Boston Scientific Corporation | $1,361.56 | 2019-2023 | Watchman Access System, Rotapro |
| Medtronic, INC. | $985.68 | 2021-2025 | Hawkone, Venaseal |
| Shockwave Medical, INC | $815.37 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $668.98 | 2019-2023 | Diamondback Coronary |
| Kestra Medical Technology Services, INC. | $640.70 | 2024-2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $421.71 | 2019-2025 | Lifevest |
| Biotronik INC. | $338.29 | 2022-2023 | Orsiro Mission, Recross |
| Stryker Corporation | $294.27 | 2025 | Flowtriever, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Janssen Pharmaceuticals, INC | $292.68 | 2021-2024 | Xarelto |
| Inari Medical, INC. | $281.45 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Philips North America LLC | $248.85 | 2019-2023 | |
| Cvrx, INC. | $170.82 | 2021-2024 | Barostim Neo System |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $169.13 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $154.11 | 2022-2025 | Camzyos |
| Novartis Pharmaceuticals Corporation | $139.59 | 2021-2025 | |
| Teleflex LLC | $81.97 | 2024 | Trapliner |
| Scpharmaceuticals INC. | $80.24 | 2024 | |
| Alnylam Pharmaceuticals INC. | $69.68 | 2025 | Onpattro, Amvuttra |
| Astrazeneca Pharmaceuticals Lp | $63.44 | 2022-2025 | Farxiga |
| Venclose INC. | $52.40 | 2020 | |
| Cleerly, INC. | $50.84 | 2024 | Cleerly Labs, Cleerly Ischemia |
| Cardiva Medical, INC. | $48.13 | 2023-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Novo Nordisk INC | $44.60 | 2024-2025 | Ozempic, Wegovy, Rybelsus |
| Merck Sharp & Dohme LLC | $39.44 | 2021 | |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $39.05 | 2019 | |
| Edwards Lifesciences Corporation | $38.88 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Impulse Dynamics (USA) INC. | $33.18 | 2023 | Optimizer |
| Glaxosmithkline, LLC. | $22.46 | 2025 | Arexvy |
| Amgen INC. | $22.32 | 2019 | |
| Vital Connect, INC | $21.87 | 2025 | Vitalpatch Rtm |
| Becton, Dickinson and Company | $21.63 | 2024 | Rotarexs 6 F X 135 Cm |
| Cashflow Solutions, LLC | $17.33 | 2025 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Angiodynamics, INC. | $13.43 | 2023 | Alphavac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepak Asti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.